A new study commissioned by AbbVie and prepared by HTANALYSTS has found that people on the ‘front line’ of caring for someone with advanced Parkinson’s disease secure the most significant gains when patients living with the condition can access standard-of-care treatments.
Australian study finds families gain the most with treatment of advanced Parkinson’s disease
March 20, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Montu pushes for national standards at Productivity Commission inquiry
June 17, 2025 - - Latest News -
Canadian appointed to lead New Zealand's Pharmac
June 17, 2025 - - Latest News -
US FDA approves CSL's treatment for hereditary angioedema
June 17, 2025 - - Latest News -
Australia's system is more uniform than the US, but not uniformly better
June 17, 2025 - - Latest News -
Australian company secures FDA approval to progress development of CAR-T therapy
June 16, 2025 - - Latest News -
These systems are and always have been more similar than most realise
June 16, 2025 - - Latest News -
Confirmation the UK has agreed to review medicine prices in response to US demand
June 16, 2025 - - Latest News